By Associated Press - Wednesday, September 19, 2018

BIDDEFORD, Maine (AP) - A University of New England pharmacy professor has received a patent for an innovation in the early detection of breast cancer.

Srinidi Mohan’s research focuses on a blood marker that can be used to detect the presence of highly aggressive tumors. He says the marker is a reliable indicator for estrogen receptor-negative tumors, the most aggressive types of breast cancer.

Mohan said Wednesday the bio-marker screening could represent a cost-effective option for early detection, monitoring disease progression, measuring treatment outcomes and providing monthly check-ups.

The American Breast Cancer Foundation says about 60,000 women are diagnosed with those tumors each year. They’re most prevalent among young women and in African-American women. Chemotherapy is the common treatment for the deadly tumors.

Copyright © 2023 The Washington Times, LLC.

Please read our comment policy before commenting.

Click to Read More and View Comments

Click to Hide